|
[1]El-Serag HB.Epidemiology of hepatocellular carcinoma in USA[J].Hepatol Res, 2007, 17Suppl2∶S88-89.
|
|
[2]Smedile A, Bugianesi E.Steatosis and hepatocellular carcinoma risk[J].Eur Rev Med Pharmacol Sci, 2005, 9 (5) ∶291-293.
|
|
[3]Haishimoto E, Yatsuji S, Kaneda H, et al.The characteristics and natural history of Japanese patients with nonalcoholic fatty liver dis-ease[J].Hepatol Res, 2005, 33 (2) ∶72-76.
|
|
[4]Ekstedt M, Franzen LE, Mathiesen DL, et al.Long-term follow-up of patients with NAFLD and elevated liver enzymes[J].Hepatol-ogy, 2006, 44 (4) ∶865-873.
|
|
[5]Regimbeau JM, Colombat M, Mognol P, et al.Obesity and diabetes as a risk factor for hepatocellular carcinoma[J].Liver Transpl, 2004, 10 (2Suppl1) S69-73.
|
|
[6]Nair S, Mason A, Eason J, et al.Is obesity an insependent risk fac-tor for hepatocellular carcinoma in cirrhosis[J]-Hepatology, 2002, 36 (3) ∶374.
|
|
[7]池肇春.肝纤维化诊治若干进展[J].临床肝胆病杂志, 2008, 24 (5) .
|
|
[8]Polesel J, Zucchetto A, Montella M, et al.The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma[J].Ann Oncol, 2008, Aug22[Epub ahead print].
|
|
[9]Ohki T, Tateishi R, Sato T, et al.Obesity is an risk factor for hepa-tocellular carcinoma development in chronic hepatitis C patients[J].Clin Gastroenterol Hepatol, 2008, 6 (4) ∶459-464.
|
|
[10]Chen C, Chang YC, Liu CL, et al.Leptin induces proliferation and anti-apoptosis in humanshepatocarcinoma cells by up-regu-lating cyclin D1and doiwn-regulating Bax via a Jauns kinase2-linked pathway[J].Endocr Relat Cancer, 2007, 14 (2) ∶513-519.
|
|
[11]Wang SN, Yeh YT, Yang SF, et al.Potential role of leptin expres-sion in hepatocellular carcinoma[J].J Clin Pathol, 2006, 59 (9) ∶930-934.
|
|
[12]Smedile A, Bugianesi E.Steatosis and hepatocellular risk[J].Eur Rev Pharmacol Sci, 2005, 9 (5) ∶291-293.
|
|
[13]Caldwell SH, Crespo DM, Kang HS, et al.Obesity and hepatocel-lular carcinoma[J].Gastroenterology, 2004, 127 (5Suppl) S97-103.
|
|
[14]Kawamura Y, Ikeda K, Arase Y, et al.Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis[J].J Gastroenterol Hepatol, 2008, Aug17[Epub ahead print].
|
|
[15]Schiel R, BeltschikowW, Steiner T, et al.Diabetes, insulin, and risk of cancer[J].Methods Find Exp Clin Pharmacol, 2006, 28 (3) ∶169-175.
|
|
[16]Lai MS, Hsieh MS, Chiu YH, et al.Type2diabetes and hepato-cellular carcinoma:A cohort study in high prevalence area of hepa-titis virus infection[J].Hepatology, 2006, 93 (6) ∶1295-1302.
|
|
[17]Davila JA, Morgan RO, Shaib Y, et al.Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study[J].Gut, 2005, 54 (4) ∶533-539.
|
|
[18]E1-Serag HB, Tran T, Everhart JE, et al.Diabetes in creases the risk of chronic liver disease and hepatocellular carcinoma[J].Gas-troenterology, 2004, 126 (2) ∶460-468.
|
|
[19]Huo TI, Lui WY, Huang YH, et al, Diabetes mellitus is a risk fac-tor forhepatic decompensation in patients with hepatocellular carci-noma undergoing resection:a longitudinal study[J].Am J Gastroen-terol, 2003, 98 (10) ∶2293-2298.
|
|
[20]Yoshioka Y, Hashimoto E, Yatsuji S, et al.Nonalcoholic steato-hepatitis:cirrhosis, hepatocellular carcinoma, and burnt-out[J].J Gastroenterol, 2004, 39 (12) ∶1215-1218.
|
PDF下载 ( 209 KB)
本文二维码
下载:
